MYDA Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-8,000
Closed -$286K 154
2017
Q4
$286K Buy
+8,000
New +$286K 0.13% 77